Use of a Predictive Regression Model for Estimating Hold-Up Volume for Biologic Drug Product Presentations

References

1. 1.↵
   1. Skalko-Basnet N.

   Biologics: The Role of Delivery Systems in Improved Therapy. Biologics 2014, 8, 107–114.

   OpenUrlPubMed
2. 2.↵
   1. Mathaes R.,
   2. Mahler H. C.,
   3. Vorgrimler L.,
   4. Steinberg H.,
   5. Dreher S.,
   6. Roggo Y.,
   7. Nieto A.,
   8. Brown H.,
   9. Roehl H.,
   10. Adler M.,
   11. Luemkemann J.,
   12. Huwyler J.,
   13. Lam P.,
   14. Stauch O.,
   15. Mohl S.,
   16. Streubel A.

   The Pharmaceutical Capping Process—Correlation between Residual Seal Force, Torque Moment, and Flip-off Removal Force. PDA J. Pharm. Sci. Technol. 2016, 70 (3), 218–229.

   OpenUrlAbstract/FREE Full Text
3. 3.↵
   1. Lambert W. J.

   Considerations in Developing a Target Product Profile for Parenteral Pharmaceutical Products. AAPS PharmSciTech. 2010, 11 (3), 1476–1481.

   OpenUrlPubMed
4. 4.↵
   1. Mathaes R.,
   2. Mahler H. C.,
   3. Roggo Y.,
   4. Huwyler J.,
   5. Eder J.,
   6. Fritsch K.,
   7. Posset T.,
   8. Mohl S.,
   9. Streubel A.

   Influence of Different Container Closure Systems and Capping Process Parameters on Product Quality and Container Closure Integrity (CCI) in GMP Drug Product Manufacturing. PDA J. Pharm. Sci. Technol. 2016, 70 (2), 109–119.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   U.S. Pharmacopeial Convention, Chapter <660> Containers-Glass. USP: Rockville, MD, 2017.
6. 6.↵
   International Organization for Standardization, ISO 8362: Injection containers and accessories. Vials made of glass tubing. Part 1: Injection. ISO: Geneva, 2009.
7. 7.↵
   International Organization for Standardization, ISO 8362: Injection containers and accessories. For injection vials. Part 2: Closures. ISO: Geneva, 2015.
8. 8.↵
   Prefilled Syringes Market, 4th Edition, 2016–2026. https://www.prnewswire.com/news-releases/prefilled-syringes-market-4th-edition-2016—2026-300395159.html.
9. 9.↵
   1. Badkar A.,
   2. Wolf A.,
   3. Bohack L.,
   4. Kolhe P.

   Development of Biotechnology Products in Pre-Filled Syringes: Technical Considerations and Approaches. AAPS PharmSciTech. 2011, 12 (2), 564–572.

   OpenUrlPubMed
10. 10.↵
    International Organization for Standardization, ISO 7886: Sterile Hypodermic Syringes for Single Use. Part 1: Syringes for manual use. ISO: Geneva, 2018.
11. 11.↵
    1. Mathaes R.,
    2. Koulov A.,
    3. Joerg S.,
    4. Mahler H. C.

    Subcutaneous Injection Volume of Biopharmaceuticals—Pushing the Boundaries. J. Pharm. Sci. 2016, 105 (8), 2255–2259.

    OpenUrlCrossRef
12. 12.↵
    Principles of Injection Technique—Becton Dickinson. www.bd.com/in-service-materials/syringes-and-needles.
13. 13.↵
    1. Berteau C.,
    2. Filipe-Santos O.,
    3. Wang T.,
    4. Rojas H. E.,
    5. Granger C.,
    6. Schwarzenbach F.

    Evaluation of the Impact of Viscosity, Injection Volume, and Injection Flow Rate on Subcutaneous Injection Tolerance. Med. Devices (Auckl) 2015, 8, 473–484.

    OpenUrlCrossRef
14. 14.↵
    U.S. Pharmacopeial Convention, Chapter <1> Injections. USP: Rockville, MD (accessed May 1, 2019).
15. 15.↵
    Allowable excess volume and labeled vial fill size in injectable drug and biological products. FDA Guidance for Industry, FDA: Rockville, MD, 2015.
16. 16.↵
    U.S. Pharmacopeial Convention, Chapter <1151> Pharmaceutical Dosage Forms. USP: Rockville, MD (accessed May 1, 2019).
17. 17.↵
    1. Sacha G.,
    2. Rogers J. A.,
    3. Miller R. L.

    Pre-Filled Syringes: A Review of the History, Manufacturing and Challenges. Pharm. Dev. Technol. 2015, 20 (1), 1–11.

    OpenUrl
18. 18.↵
    1. Jarrahian C.,
    2. Rein-Weston A.,
    3. Saxon G.,
    4. Creelman B.,
    5. Kachmarik G.,
    6. Anand A.,
    7. Zehrung D.

    Vial Usage, Device Dead Space, Vaccine Wastage, and Dose Accuracy of Intradermal Delivery Devices for Inactivated Poliovirus Vaccine (IPV). Vaccine 2017, 35 (14), 1789–1796.

    OpenUrl
19. 19.↵
    1. Allmendinger A.,
    2. Fischer S.,
    3. Huwyler J.,
    4. Mahler H. C.,
    5. Schwarb E.,
    6. Zarraga I. E.,
    7. Mueller R.

    Rheological Characterization and Injection Forces of Concentrated Protein Formulations: An Alternative Predictive Model for non-Newtonian Solutions. Eur. J. Pharm. Biopharm. 2014, 87 (2), 318–328.

    OpenUrl
20. 20.↵
    1. Fischer I.,
    2. Schmidt A.,
    3. Bryant A.,
    4. Besheer A.

    Calculation of Injection Forces for Highly Concentrated Protein Solutions. Int. J. Pharm. 2015, 493 (1-2), 70–74.

    OpenUrl
21. 21.↵
    1. Rathore N.,
    2. Pranay P.,
    3. Bernacki J.,
    4. Eu B.,
    5. Ji W.,
    6. Walls E.

    Characterization of Protein Rheology and Delivery Forces for Combination Products. J. Pharm. Sci. 2012, 101 (12), 4472–4480.

    OpenUrlPubMed
22. 22.↵
    1. Forcinio H.

    Selecting Primary Packaging for Parenterals. Pharmaceut. Technol. 2018, 42 (7), 46–50.

    OpenUrl
23. 23.↵
    U.S. Pharmacopeial Convention, Chapter <7864> Sterile Hypodermic Needles for Single Use—Requirements and Test Methods. USP: Rockville, MD, 2016.
24. 24.↵
    1. Raut A. S.,
    2. Kalonia D. S.

    Viscosity Analysis of Dual Variable Domain Immunoglobulin Protein Solutions: Role of Size, Electroviscous Effect and Protein-Protein Interactions. Pharm. Res. 2016, 33 (1), 155–166.

    OpenUrl
25. 25.↵
    1. Huggins M. L.

    The Viscosity of Dilute Solutions of Long-Chain Molecules. IV. Dependence on Concentration. J. Am. Chem. Soc. 1942, 64 (11), 2716–2718.

    OpenUrlCrossRefWeb of Science
26. 26.↵
    1. Gonzalez-Tello P.,
    2. Camacho F.,
    3. Blazquez G.

    Density and Viscosity of Concentrated Aqueous Solutions of Polyethylene Glycol. J. Chem. Eng. Data 1994, 39 (3), 611–614.

    OpenUrlCrossRef
27. 27.↵
    U.S. Pharmacopeial Convention, Chapter <697> Container Content for Injections, USP: Rockville, MD, 2015.
28. 28.↵
    1. Siew A.

    Delivering Biologics in Prefilled Syringes. BioPharm Int. 2017, 30 (11),
29. 29.↵
    1. Ingle R. G.,
    2. Agarwal A. S.

    Pre-Filled Syringe—a Ready-to-Use Drug Delivery System: A Review. Expert Opin. Drug Deliv. 2014, 11 (9), 1391–1399.

    OpenUrl